Revisiting the dynamics of gaseous ammonia and ammonium aerosols during the COVID-19 lockdown in urban Beijing using machine learning models.

The concentration of atmospheric ammonia (NH3) in urban Beijing substantially decreased during the COVID-19 lockdown (24 January to 3 March 2020), likely due to the reduced human activities. However, quantifying the impact of anthropogenic interventions on NH3 dynamics is challenging, as both meteorology and chemistry mask the real changes in observed NH3 concentrations. Here, we applied machine learning techniques based on random forest models to decouple the impacts of meteorology and emission changes on the gaseous NH3 and ammonium aerosol (NH4+) concentrations in Beijing during the lockdown. Our results showed that the meteorological conditions were unfavorable during the lockdown and tended to cause an increase of 8.4 % in the NH3 concentration. In addition, significant reductions in NOx and SO2 emissions could also elevate NH3 concentrations by favoring NH3 gas-phase partitioning. However, the observed NH3 concentration significantly decreased by 35.9 % during the lockdown, indicating a significant reduction in emissions or enhanced chemical sinks. Rapid gas-to-particle conversion was indeed found during the lockdown. Thus, the observed reduced NH3 concentrations could be partially explained by the enhanced transformation into NH4+. Therefore, the sum of NH3 and NH4+ (collectively, NHx) is a more reliable tracer than NH3 or NH4+ alone to estimate the changes in NH3 emissions. Compared to that under the scenario without lockdowns, the NHx concentration decreased by 26.4 %. We considered that this decrease represents the real decrease in NH3 emissions in Beijing due to the lockdown measures, which was less of a decrease than that based on NH3 only (35.9 %). This study highlights the importance of considering chemical sinks in the atmosphere when applying machine learning techniques to link the concentrations of reactive species with their emissions.

Dexmedetomidine alleviates host ADHD-like behaviors by reshaping the gut microbiota and reducing gut-brain inflammation.

Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent psychiatric disorders that affects children and even continues into adulthood. Dexmedetomidine (DEX), a short-term sedative, can selectively activate the α2-adrenoceptor. Treatment with α2-adrenergic agonists in patients with ADHD is becoming increasingly common. However, the therapeutic potential of DEX for the treatment of ADHD is unknown. Here, we evaluated the effect of DEX on ADHD-like behavior in spontaneously hypertensive rats (SHRs), a widely used animal model of ADHD. DEX treatment ameliorated hyperactivity and spatial working memory deficits and normalized θ electroencephalogram (EEG) rhythms in SHRs. We also found that DEX treatment altered the gut microbiota composition and promoted the enrichment of beneficial gut bacterial genera associated with anti-inflammatory effects in SHRs. The gut pathological scores and permeability and the level of inflammation observed in the gut and brain were remarkably improved after DEX administration. Moreover, transplantation of fecal microbiota from DEX-treated SHRs produced effects that mimicked the therapeutic effects of DEX administration. Therefore, DEX is a promising treatment for ADHD that functions by reshaping the composition of the gut microbiota and reducing inflammation in the gut and brain.

Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus-associated host cognitive impairment.

Attention-deficit/hyperactivity disorder (ADHD) is a highly heterogeneous psychiatric disorder that can have three phenotypical presentations: inattentive (I-ADHD), hyperactive-impulsive (HI-ADHD), and combined (C-ADHD). Environmental factors correlated with the gut microbiota community have been implicated in the development of ADHD. However, whether different ADHD symptomatic presentations are associated with distinct microbiota compositions and whether patients could benefit from the correction of aberrant bacterial colonization are still largely unclear. We carried out metagenomic shotgun analysis with 207 human fecal samples to characterize the gut microbial profiles of patients with ADHD grouped according to their phenotypical presentation. Then, we transplanted the candidate low-abundance bacteria identified in patient subgroups into ADHD rats and evaluated ADHD-associated behaviors and neuronal activation in these rats. Patients with C-ADHD had a different gut microbial composition from that of healthy controls (HCs) (p = .02), but not from that of I-ADHD patients. Eight species became progressively attenuated or enriched when comparing the compositions of HCs to those of I-ADHD and C-ADHD; in particular, the abundance of Bacteroides ovatus was depleted in patients with C-ADHD. In turn, Bacteroides ovatus supplementation ameliorated spatial working memory deficits and reversed θ electroencephalogram rhythm alterations in ADHD rats. In addition, Bacteroides ovatus induced enhanced neuronal activation in the hippocampal CA1 subregion. These findings indicate that gut microbial characteristics that are unique to patients with C-ADHD may be masked when considering a more heterogeneous group of patients. We link the gut microbiota to brain function in an ADHD animal model, suggesting the relevance of testing a potential bacteria-based intervention for some aspects of ADHD.